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DObjective:We have previously shown that surgical Technical Performance Scores (TPS) are important predic-
tors of early postoperative morbidity across a wide spectrum of procedures and that intraoperative recognition
and intervention of residual defects resulted in improved outcomes. We hypothesized that these scores would
also be important predictors of midterm outcomes.
Methods: Neonates and infants aged younger 6 months were prospectively followed from the index surgery for
a minimum of 1 year. The TPS were calculated using previously published criteria, including intraoperative
course, predischarge echocardiograms or catheterizations, and clinical data, and graded as optimal, adequate,
or inadequate. Case complexity was determined by the Risk Adjustment for Congenital Heart Surgery-1 cate-
gory. The primary outcome was mortality, and the secondary outcome was the need for unplanned reinterven-
tions. Outcomes were analyzed using nonparametric methods and a logistic regression model.
Results:A total of 166 patients were included in our study, with 7 early deaths. The remaining 159 patients (Risk
Adjustment for Congenital Heart Surgery-1 category 4-6, 76 [48%]; neonates, 78 [49%]) were followed for
a minimum of 1 year after surgery. There were 14 late deaths or late transplantations and 55 late reinterventions.
On univariate analysis, the TPS were associated with mortality (P<.001) and reintervention (P ¼ .04). On lo-
gistic regression analysis, inadequate TPS was associated with late mortality (P<.001; odds ratio, 7.2; 95%
confidence interval, 2.2-23.6), and Risk Adjustment for Congenital Heart Surgery-1 category (P ¼ .004; odds
ratio, 3.7; 1.5-8.8) at index surgery was associated with need for late unplanned reintervention.
Conclusions: Technical performance affects midterm survival after infant heart surgery. Inadequate TPS can be
used to prospectively identify patients at ongoing risk of demise and the need for reintervention. An aggressive
approach to diagnosing and treating residual lesions at the initial operation is warranted. (J Thorac Cardiovasc
Surg 2012;144:1095-101)Supplemental material is available online.
The outcome of congenital cardiac surgery, particularly in
neonates and young infants, is dependent on multiple fac-
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important contributory role.7-9
In initial work from our institution,10,11 we had developed
a Technical Performance Score (TPS) for several individual
procedures, including ventricular sepal defect repair,
complete atrioventricular canal repair, tetralogy of Fallot
repair, arterial switch operation, and stage I Norwood
repair. The TPS grades the performance of the planned
surgical procedure according to how closely the anatomic
and functional result achieved the intended optimal
outcome. In these studies, we have shown that the TPS
correlates highly with the risk of complications and
mortality and length of hospital stay in high-risk proce-
dures. In a subsequent study,2 we were also able to show
that in high-risk infants, an optimal technical score was
able to mitigate the contribution of greater case complexity
and greater preoperative illness severity.
In our latest published study,1 we prospectively followed
166 infants younger than 6 months of age, who underwent
correction of congenital cardiac defects on cardiopulmo-
nary bypass and found that technical performancediovascular Surgery c Volume 144, Number 5 1095
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RACHS-1 ¼ Risk Adjustment for Congenital
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Dcorrelated highly with the occurrence of major postopera-
tive adverse events, after correcting for disease complexity
and physiologic status. In our present study, we considered
the midterm outcomes in the same cohort of patients. We
hypothesized that the TPS would be able to predict the mid-
term outcomes and, thus, serve as a tool that could guide
early intervention and ultimately improve long-term results.MATERIALS AND METHODS
The institutional review board approved the present study.
In the initial cohort of 166 neonates and infants younger than 6 months
old who had been followed prospectively from October 2008 to April 2010
from admission to discharge (data previously published),1 7 early deaths
occurred. In the present study, the remaining 159 patients were followed
after discharge from their index operation. Our endpoints of interest
were mortality or the need for transplantation and the need for late interven-
tion, either surgical or catheter based, or both, during the follow-up period,
which ended March 2012.
Case complexity was scored using the Risk Adjustment for Congenital
Heart Surgery-1 (RACHS-1) scoring system.4-6 The TPS was assigned
according to the anatomic and functional information obtained from the
discharge echocardiogram and clinical status at discharge from the index
operation as optimal, adequate, or inadequate using a previously
published method.10,11 The need for surgical or catheter-based reinterven-
tion for residual or recurrent lesions on the operated structures or the need
for permanent pacemaker placement before discharge from index operation
resulted in a TPS of inadequate.
Late mortality was defined as death or transplantation occurring more
than 30 days after the index surgery for those patients discharged home
less than 30 days after surgery. For patients discharged home more than
30 days after the index surgery, late mortality was defined as death or trans-
plantation occurring any point after discharge.
Late reinterventions included any unplanned surgical or catheter-based
intervention to treat a residual or recurrent lesion that occurred after dis-
charge from the index surgery. For the purposes of the present study, for
the neonates who underwent a Norwood stage I operation as their index
procedure, a straightforward second-stage procedure or bidirectional Glenn
procedure was not considered a reintervention.
Statistical Analysis
Categorical variables are represented as numbers and percentages, and
continuous variables are summarized as median and range or mean stan-
dard deviation. The Pearson c2 test was used to compare proportions for
categorical variables. A bivariate association was used to choose variables,
with P< .05 for inclusion in logistic regression analysis. Multivariate
logistic regression analysis was used to examine the association between
technical performance and late outcomes, adjusting for age and case com-
plexity. IBM SPSS Statistics, version 18, for Window (SPSS Inc, Somers,
NY) was used for statistical analysis.RESULTS
A total of 159 patients were included in the present study.
Of these, 89 (56%) were male, and 78 (49%) were neonates1096 The Journal of Thoracic and Cardiovascular Surat the index surgery. Of the 159 patients, 40 (25%) were
in RACHS-1 category 2, 42 (26%) were in RACHS-1 cat-
egory 3, 43 (27%) were in RACHS-1 category 4, and 34
(21%) were in RACHS-1 category 6. The discharge TPSs
were as follows: optimal in 59 (37%), adequate in 77
(48%), and inadequate in 23 (14%; Table 1). Table E1 out-
lines the percentage of distribution of RACHS-1 categories
in each of the TPS groups.
The mean duration of follow-up was 17  8 months. The
median duration of follow-up was 17 months (range, 1-35).
Of the 159 patients, 14 died or required late transplanta-
tion (4 late transplants). Of these 14 patients, 6 were in the
optimal group (10.2%), 1 in the adequate group (1.3%), and
7 in the inadequate group (30%). Also, 55 patients (35%)
required 78 reinterventions.
The reinterventions included surgical or catheter inter-
ventions on the right ventricular outflow tract or main or
branch pulmonary arteries in 37 patients; surgical or cathe-
ter interventions on the ascending aorta or arch in 10;
surgical or catheter interventions on the Sano or Blalock-
Taussig shunt in 8; surgical or catheter interventions on
the atrial septum in 4; surgical or catheter interventions
on the pulmonary veins in 3 (2 after total anomalous pulmo-
nary venous return repair and 1 after tetralogy of Fallot/ab-
sent pulmonary valve repair); surgical or catheter
interventions on atrioventricular valve in 5; surgical or
catheter interventions on systemic vein in 2; closure of re-
sidual atrial or ventricular septal defect in 2; late permanent
pacemaker in 2; surgical intervention in subaortic region in
2; and transplantation in 4.
Table E2 outlines the initial index operation and in-
dications for late reinterventions. Figures E1 to E6
depict the occurrence of mortality and the need for late
reintervention according to TPS, RACHS-1 category, and
age at intervention.
Late Mortality/Transplantation
On univariate analysis, a worse TPS was significantly as-
sociated with mortality (P<.001). However, the RACHS-1
category and age at index surgery were not significantly as-
sociated with late mortality (Table 2). A significant associa-
tionwas seen between late mortality and late reinterventions
(P ¼ .033; Table E3).
On stratified analyses, mortality was greater in the inad-
equate group for both neonates and non-neonate infants and
in both higher and lower RACHS categories (Table E4).
This indicates that the greater mortality in the inadequate
group did not result from confounding by either age or
complexity.
On bivariate logistic regression analysis, an inadequate
TPS was associated with greater late mortality compared
with the risk of death in the optimal/adequate groups, ad-
justing for either age or RACHS category (P ¼ .001; odds
ratio, 7.2; 95% confidence interval, 2.2-23.6). We couldgery c November 2012
TABLE 1. Patient characteristics
Characteristic Value
Age at surgery (d)
Median 32
Range 0-156
Neonate
Yes 78 (49%)
No 81 (51%)
RACHS-1 risk category
2-3 (low risk) 83 (52%)
4-6 (high risk) 76 (48%)
TPS
Optimal 59 (37%)
Adequate 77 (48%)
Inadequate 23 (14%)
Any late reintervention
None 104 (65%)
Catheter based 25 (16%)
Surgical 9 (6%)
Catheter based and surgical 21 (13%)
Late death or transplant
No 145 (91%)
Yes 14 (9%)
RACHS-1, Risk Adjustment for Congenital Heart Surgery-1; TPS, Technical Perfor-
mance Score.
TABLE 3. Bivariate logistic regression analysis of late mortality/
transplantation
Variable OR 95% CI P value
TPS for patient age
Optimal/adequate 1.0 — —
Inadequate 7.2 2.2-23.6 .001
Neonate
Yes 2.3 0.7-8.0 .20
No 1.0 — —
TPS for RACHS-1 category
Optimal/adequate 1.0 — —
Inadequate 7.4 2.2-24.4 .001
RACHS-1 category
2-3 1.0 — —
4-6 1.5 0.4-5.0 .53
OR,Odds ratio; CI, confidence interval; TPS, Technical Performance Score; RACHS-
1, Risk Adjustment for Congenital Heart Surgery-1.
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the relatively small number of deaths (Table 3).
Need for Any Late Reintervention
On univariate analysis, the TPS was significantly associ-
ated with the need for surgical or catheter-based reinterven-
tions in the area considered inadequate (P ¼ .04), as were
the RACHS-1 category (P< .001) and patient age at the
index operation (P ¼ .02; Table 4).
On stratified analyses, no relationship was found between
the TPS and the need for late reintervention in neonates. In
older infants, however, the inadequate group was associatedTABLE 2. Univariate analysis of late mortality/transplantation
Variable Patients (n) Deaths (n) P value
TPS <.001
Optimal 59 6 (10.2%)
Adequate 77 1 (1.3%)
Inadequate 23 7 (30.4%)
TPS group <.001
Optimal/adequate 136 7 (5.2%)
Inadequate 23 7 (30.4%)
Neonate .10
Yes 78 10 (12.8%)
No 81 4 (4.9%)
RACHS-1 category .27
2-3 83 5 (6.0%)
4-6 76 9 (11.8%)
TPS, Technical Performance Score; RACHS-1, Risk Adjustment for Congenital Heart
Surgery-1.
The Journal of Thoracic and Carwith a greater reintervention rate (P ¼ .03; Table E5).
Similarly, no relationship was found between the TPS and
reintervention in patients in higher RACHS-1 categories.
However, among the lower RACHS-1 categories, an inade-
quate TPS was associated with a greater rate of reinterven-
tions (P ¼ .03; Table E4).
On multivariate logistic regression analysis, RACHS-1
category (P¼ .004; odds ratio, 3.7; 95% confidence interval,
1.5-8.8) was significantly associated with the need for late
unplanned reintervention. However, after adjusting for age
and complexity, the odds of late reintervention were not sig-
nificantly greater in the inadequate TPS group (Table 5).DISCUSSION
The TPS of surgical procedures performed on young
infants with congenital heart defects have been shown to
correlate highly with early mortality and/or morbidity.1,2,11
In the present study, we have followed the same cohort ofTABLE 4. Univariate analysis of need for late reintervention factors
associated with late reintervention
Variable Patients (n) Reintervention (n) P value
TPS .04
Optimal 59 23 (39.0%)
Adequate 77 20 (26.0%)
Inadequate 23 12 (52.2%)
TPS group .06
Optimal/adequate 136 43 (31.6%)
Inadequate 23 12 (52.2%)
Neonate .02
Yes 78 34 (43.6%)
No 81 21 (25.9%)
RACHS-1 category <.001
2-3 83 17 (6.0%)
4-6 76 38 (50.0%)
TPS, Technical Performance Score; RACHS-1, Risk Adjustment for Congenital Heart
Surgery-1.
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TABLE 5. Multivariate logistic regression analysis of need for late
reintervention
Variable OR 95% CI P value
TPS
Optimal/adequate 1.0 — —
Inadequate 1.8 0.7-4.6 .21
Neonate
Yes 1.0 0.4-2.3 .98
No 1.0 — —
RACHS-1 category
2-3 1.0 — —
4-6 3.7 1.5-8.8 .004
OR, Odds ratio; CI, confidence interval; TPS, Technical Performance Score; RACHS-
1, Risk Adjustment for Congenital Heart Surgery-1.
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1 and found that the TPSs can also predict the
midterm outcomes after correcting for other risk factors
such as disease complexity and age.
In unadjusted analyses, the inadequate group was signif-
icantly worse than the optimal/adequate group with respect
to occurrence of late death. Although the late mortality
rates are greater in neonates and infants in higher
RACHS categories, these differences are not statistically
significant.
The stratified analyses suggest that mortality is greater
in the inadequate group for both neonates and non-
neonates and in both higher and lower RACHS categories.
This indicates that the greater mortality in the inadequate
group was not due to confounding by either age or proce-
dure complexity. The relationship between inadequate
technical performance and greater mortality remained af-
ter controlling for age, and for RACHS-1 risk category.
The relationship between TPS and late reintervention
was weaker than the relationship between TPS and
late mortality; however, there is still some evidence that
the inadequate group is more likely to experience late rein-
tervention than the optimal/adequate group. The rates of
late reintervention were greater among neonates and those
in greater RACHS categories. However, stratified analyses
suggest that no relationship was found between the TPS
and reintervention in neonates (rates of reintervention
were consistently high in neonates compared with older in-
fants, regardless of the TPS). In older infants, however, the
inadequate group was associated with a greater reinterven-
tion rate. Similarly, no relationship was found between the
TPS and reintervention in patients in higher risk categories.
However, among the lower risk categories, inadequate TPS
was associated with a greater reintervention rate. Thus, the
TPS did not have a demonstrable effect on the reinterven-
tion rate in the highest risk infants. This observation might
have been because of the greater mortality rate in this sub-
group, such that an inadequate TPS in the higher complexity
and risk procedures likely results in a more life-threatening
abnormality in physiology. Alternatively, it could be that the
nature of the TPS, because it is based on findings from the1098 The Journal of Thoracic and Cardiovascular Surearly postoperative echocardiogram, is not sensitive enough
to detect subtle imperfections in technical performance that
affect only late outcomes.
The present study cohort consisted of infants younger
than 6 months old, with 49% neonates and 48% in the
high risk RACHS-1 categories. Thus, this cohort repre-
sented a relatively broad distribution across risk categories.
We chose the postdischarge mortality and need for reinter-
ventions as our intermediate outcomes of interest because
these are well-documented hard endpoints. Despite the
cohort size, our findings suggest that the TPS can predict
the midterm outcomes. Although late mortality and the
need for late reintervention are reasonable outcomes to fol-
low, the rapidly improving outcomes of surgery for even the
most complex of congenital defects suggests that more sen-
sitive outcomes measures might need to be followed. To this
end, we are also evaluating the neurodevelopmental
outcomes in a subset of these patients to determine whether
the technical performance correlates with this measure.
Future Directions
Mortality has long been used as an outcome measure,
particularly for early outcomes in database research. How-
ever, several studies have shown that the use of mortality
data might not effectively reflect a surgeon’s performance
because of the multiple associated factors that can contrib-
ute to mortality in any specific congenital cardiac diagno-
sis.12,13 Although risk adjustment does allow a more
uniform comparison, the use of clinical and administrative
databases to derive this information has the inherent
problem of voluntary data submission and incomplete/
partial data collection. Few data are available on the
long-term outcomes from such database research. Several
initiatives are in place to unify data collection methods so
more accurate and complete data can be accrued in each di-
agnostic group,14-20 particularly, long-term data such as late
mortality and late reinterventions. The TPS can serve as
a surrogate, and its inclusion into national and international
databases could allow the expansion of this tool to a wider
group of patients for validation.
Study Limitations
The present study included a small number of patients
and in a specific age group. Additional study is required
to validate this finding across a broad spectrum of diagnosis
and procedures, and for all age groups.
Long-term data, not only on mortality, but also on more
subtle outcomes, such as quality of life, neurodevelopmen-
tal outcomes, and psychosocial adjustments for the patients,
as well as the family, might also be important measures of
the efficacy of surgical performance in this group.21-23
Resource use in the form of multiple readmissions could
be another important factor that should be measured.
Whether the TPS might well serve as surrogate forgery c November 2012
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short term, but also in the intermediate and long term,
needs to be determined, because studies22,23 have shown
that patient-related and environmental factors are more
likely to contribute to neurodevelopmental outcomes in
specific subset of patients such as those undergoing the Nor-
wood stage I procedure and arterial switch operation.
Although this tool has been validated in 1 center for spe-
cific outcomes and specific subsets of patients, a multicenter
study is necessary to establish its reproducibility across
a wide range of diagnostic and procedural categories and
across a wide range of programs. The use of echocardiogra-
phy as the principle component of the TPS is advantageous,
because it is routinely obtained perioperatively and during
long-term follow-up in all centers. However, its disadvan-
tage is the variability in the interpretation of the findings.
We believe that standardization of the TPS modules will
allow for more uniform data collection.
CONCLUSIONS
The TPS, based on early operative results determined by
echocardiography at discharge and the need for early rein-
tervention to correct residual or recurrent defects, correlates
highly with both early- and intermediate-term outcomes.
The present study underscores the need for early assessment
of adequacy of the surgical procedure in addressing impor-
tant hemodynamic lesions and justifies an aggressive
approach to early intervention of residual defects.
We would like to acknowledge Kimberly Gauvreau, ScD, for
assistance with statistics, and Kathy Jenkins, MD, and the Program
for Patient Safety and Quality for pilot funding of this project.
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David M. Overman (Minneapolis, Minn). Meena, congratula-
tions on an excellent presentation and thank you for providing the
report well in advance of the meeting for review.
This work builds on a characteristically expansive foundation of
human factors research laid by Marc de Leval nearly 20 years ago.
Human factors are, of course, quite complex and difficult to
quantify. They include individual, technical, and organizational di-
mensions. Dr Bacha and his colleagues should be commended for
successfully filtering out 1 specific human factor, intraoperative
technical performance, and exploring its effect on outcomes
through a series of investigations now dating back to 2007.
The present study assesses the role of the TPS on late mortality
and unanticipated reintervention at a mean follow-up of 17
months. It extends the analysis of a prospective cohort of newbornsdiovascular Surgery c Volume 144, Number 5 1099
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Dand infants presented at last year’s American Association for
Thoracic Surgery, a study that demonstrated the ability of techni-
cal performance to mitigate the effects of adverse intraoperative
events. The main findings of the present study are that the TPS
is strongly associated with late mortality or the need for transplan-
tation. Although this association is somewhat weaker when ad-
justed for age and complexity, it is particularly sobering to note
that survival at 2 years is a startling 50% among patients whose
TPS was inadequate.
Second, age and complexity did not correlate with late mortality
or the need for transplantation, although this is probably explained
by inadequate statistical power. The TPS is more weakly associ-
ated with late reintervention and in the report this association is
limited to non-neonates and patients with lower complexity.
Finally, on multivariate analysis, complexity alone was
associated with the need for late reintervention; notably, patients
requiring reintervention had a mortality rate of 15%.
I have 3 questions for the authors.
Number 1, it strikes me as counterintuitive that an inadequate
TPS does not significantly increase the risk of the need for reinter-
vention. The significant incidence of mortality among patients un-
dergoing reintervention and the strong association of TPS with late
mortality would seem to support a connection between TPS and
reintervention. Can you share with us more specific information
regarding the nature of these reinterventions, and does that data
offer any explanation for this apparent paradox?
Dr Nathan. I would like to bring to your attention that in the
initial cohort of 166 patients we had 7 early deaths, and most of
them, 6 of the 7 were in the high-risk category and were in
neonates, and 6 of the 7 had an inadequate technical performance.
Thus, if these patients had survived, the chances are that they
would have required multiple reinterventions or would have had
late deaths.
Unfortunately, our study was underpowered, because we only
had 159 patients. Also, if we had a larger subset of patients, we
probably could prove that inadequate TPSs would definitely be as-
sociated with the need for late reintervention, in addition to late
mortality.
DrOverman. Second, the TPS is based almost entirely on post-
operative echocardiographic assessment of residual disease. This
method has some potential weaknesses. One of these is that by
equating residual disease and technical performance, we introduce
confounding variables that impair the evaluation of technical per-
formance alone. For instance, what if the surgeon intentionally
leaves a residual gradient at the level of the pulmonary valve
during tetralogy repair, should that be considered technically
less than optimal? Should imperfect native anatomy really effect
TPS?
Dr Nathan. I agree that the TPS is not yet a perfect system, and
we are in the process of tweaking it, particularly for certain
diagnostic groups such as valve-sparing tetralogy repairs, valve
repairs, and, in fact, even for canal repairs, because often in canal
repairs, we accept trivial to mild regurgitation as acceptable, but
that would classify it as an adequate score, rather than an optimal
score.
We are in the process of modifying our TPS, and, hopefully,
after we have accrued enough data on each of these subgroups,
we might come up with a refined score.1100 The Journal of Thoracic and Cardiovascular SurDr Overman. Finally, we all know that one can perform a tech-
nically perfect operation but still lose the patient to the hazards of
the early postoperative environment, many of these hazards being
human factors. Have the authors considered study designs that at-
tempt measurement of other types of human factors, either alone or
combined with TPS and whether there any human factors you
would consider particularly important investigative targets for
those in the audience who might want to take up the baton?
Dr Nathan. I agree with the discussant that there are several
factors, in addition to technical performance, that will contribute
to the outcomes and a many of them are human factors, namely,
the cognitive factors, communication between the various teams
involved in the care of the patient, both intraoperatively and post-
operatively, and several other human factors that are closely inter-
related.We concentrated on the TPSs and, hopefully, oncewe have
refined it, we will study these other human factors, which we also
believe play an important part in outcomes.
Dr Overman. Thank you and congratulations on this work.
Dr V. Mohan Reddy (Stanford, Calif). Meena, I would like to
ask a question. I agree that technical performance is an important
factor in early and late outcomes, but the paper is so abstract when
you say ‘‘highly complex’’ and ‘‘interventions.’’ Can you tell me 1,
2, 3, in each category, what were the most complex diagnoses,
what were the 1, 2, 3 residual defects that required reintervention.
Dr Nathan. I have a list of the 55.
Dr Reddy. Just give me the top 3.
Dr Nathan. Most of them were pulmonary artery reinterven-
tions. Most of them, in the stage 1 and in the Tet groups, especially
the Tet pulmonary atresia MAPCAs, the other was arch interven-
tions, and the third was either redo valve repair or subaortic inter-
ventions in the canals.
Dr Reddy. So how many were single ventricle or is this
2-ventricle patients who participated?
DrNathan.About 50% to 60%were single ventricle. A number
of the reinterventions were in the single-ventricle group, which is
to be expected. Even when they had an optimal technical perfor-
mance, at their discharge echocardiogram, a number of them re-
quired reinterventions.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
Dr Nathan, it is no secret I am a big fan of this work that you
have been pioneering. A couple questions.
One, I noticed on a couple of the slides, I think it was the late
interventions, and it might have even been early mortality, that
the ‘‘optimals’’ actually seemed to fare worse than the ‘‘ade-
quates.’’ I assume that was not statistically significant, but it was
a bit of a trend. Do you have any explanation for that? Because
it certainly would not have been expected.
Dr Nathan. The reason for that is a lot of the stage 1 cases, more
than 50%of the stage 1 cases, were in the optimal group, but a num-
ber required either arch reintervention or reintervention on their
shunts. We do have a very aggressive interventional cardiac pro-
gram; and during pre-bidirectional Glenn cardiac catheterization,
even if they see a minor arch gradient, they tend to balloon dilate,
and those patients were included in our reintervention group.
Also, a number of the adequate group belonged in the low-risk
RACHS category, namely, tetralogy of Fallot and canals; and, in
them, even an adequate technical score did not seem to require
late reintervention. Also, that might explain why the ‘‘adequates’’gery c November 2012
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vention curves than the optimal patients.
Dr Caldarone. However, your first example was that some pa-
tients, for example Norwood, might have had an optimal outcome
in terms of the paradigm of the TPS but might have actually had
a lesion that required reintervention.
Dr Nathan. Yes. Not at discharge but developed that lesion
subsequently.
Dr Caldarone. Subsequently, I see.
Dr Nathan. Yes, they had an optimal score at discharge.
Dr Caldarone. So, presumably as your TPSs are modified and
calibrated to the patient populations, they will come more in line
with expectations and the prediction of reintervention.
Dr Nathan.Yes. We are in the process of accruing about 100 to
150 patients in each of these diagnoses so that we can further
modify the TPSs.
Dr Caldarone. Do you think you will be adding additional pa-
rameters to measure, or will you be redefining the cutpoints among
optimal, adequate, and inadequate?
Dr Nathan.We will initially redefine the cutpoints because we
find that what we classify as mild regurgitation on discharge echo-
cardiography in canals is often read as trivial on the follow-up
echocardiogram, even though the vena contracta appears the same.
So,wewill initially redefine the cutoff among optimal, adequate,
and inadequate and then we will consider weighting each of the
subcategories and procedures to determine which is more impor-
tant and is more likely to need reintervention or cause an adverse
outcome late during follow-up. For example, in a Norwood proce-
dure, is arch reobstruction more significant than a restrictive atrial
septum or a slightly narrow shunt? All of that needs to be redefined.
Dr Caldarone. So you redefine the cutpoints and add coeffi-
cients or weighting coefficients?
Dr Nathan. Yes.
Dr Marshall Jacobs (Newtown Square, Pa). I want to compli-
ment you as everyone has. We have followed this research with
great interest since the initial development of the tool. Also, oneThe Journal of Thoracic and Carof my recollections of your earlier reports of the short-term out-
comes and resource use is that the relationship between the TPS
and those measures varied between procedure groups, that there
are procedures for which suboptimal technical performance might
be associated with longer hospital stay or different measures of
outcome.
What you did in this study certainly makes sense. It is a very
logical next step. But, really, this was an example of lumping,
where the previous analyses were examples of splitting. Also,
you really only stratified the patients here by their theoretical com-
plexity as measured by RACHS, which is based on the estimated
risk of mortality. So I wonder, going forward, as you accrue
more data on more patients, as you have said you have to do,
whether it will not be most appropriate to consider these midterm
outcomes in relation to specific procedural groups.
I mean being left with a residual ventricular septal defect after
a ventricular septal defect repair has very different physiologic
consequences than being left with arch obstruction after aNorwood
operation. Also, the overall expectations of a suboptimal outcome
for 1 operation in terms of the survivability and functional status of
the patient are very different than the overall expectations of the
midterm outcomes for another operation.
So I compliment you on taking this to the next step, which was
a natural progression, but I think really to find insights into the
midterm associations with TPS, it is going to have to be broken
down into procedural groups, isn’t it?
DrNathan. I totally agreewith you, and we are in the process of
accruing these data. In our previous work on the initial presenta-
tion of 166 patients, we did show that an inadequate technical per-
formance in the high-risk group was associated with increased
mortality across all ranges. Thus, if you had an adequate technical
performance, you did well if you were low risk, but did poorly if
you were high risk. Also, if you had optimal technical perfor-
mance, you did relatively well in all risk categories. We agree
that considering specific procedures will give us a better insight
into what lesions need preemptive reintervention.diovascular Surgery c Volume 144, Number 5 1101
FIGURE E1. Relationship between Technical Performance Scores and late mortality and need for late reintervention. An inadequate Technical Perfor-
mance Score was associated with a significantly greater late mortality and need for late reintervention.
FIGURE E2. Relationship between Risk Adjustment for Congenital Heart Surgery-1 (RACHS-1) category and late mortality and need for late reinterven-
tions. High-risk RACHS-1 category (RACHS-1 category 4-6) was associated with a significantly greater need for late reintervention.
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FIGURE E3. Relationship between neonates and late mortality and need for late reintervention. Neonatal age was associated with a significantly greater
need for late reintervention.
FIGURE E4. Kaplan-Meier curve representing freedom from late mortality and need for late reinterventions according to age at index surgery. Patients
who were neonates at the index surgery had a significantly greater need for late reinterventions.
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FIGURE E5. Kaplan-Meier curve representing freedom from late mortality and need for late reinterventions according to Technical Performance Score.
Inadequate Technical Performance Score was associated with significantly greater late mortality and need for late reintervention. RACHS-1, Risk Adjust-
ment for Congenital Heart Surgery-1.
FIGURE E6. Kaplan-Meier curve representing freedom from late mortality and need for late reinterventions according to Risk Adjustment for Congenital
Heart Surgery-1 (RACHS-1) category. High-risk RACHS-1 category (RACHS-1 category 4-6) was associated with a significantly greater need for late
reintervention.
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TABLE E1. Distribution of RACHS-1 categories across TPS groups
TPS
RACHS-1 category
Total2 3 4 6
Optimal 14 (35%) 10 (24%) 18 (42%) 17 (50%) 59
Adequate 26 (65%) 25 (59%) 15 (35%) 11 (32%) 77
Inadequate 0 (0%) 7 (17%) 10 (23%) 6 (18%) 23
Total 40 42 43 34 159
RACHS-1, Risk Adjustment for Congenital Heart Surgery-1; TPS, Technical Perfor-
mance Score.
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TABLE E2. Late reinterventions stratified by RACHS-1 category and TPS
RACHS-1 category Diagnosis Procedure TPS Reintervention detail
Category 6 (n ¼ 21)
HLHS Stage I 1 BD of CoA, LPA, OHT
HLHS Stage I 1 BD of CoA, TV-plasty at BDG
HLHS Stage I 1 Stenting of Sano, stenting of ASD
before BDG, atrial septectomy
at BDG
HLHS Stage I 1 BD of ASD and PA, stenting of ASD
HLHS Stage I 1 Stenting of Sano, atrial septectomy
at BDG
HLHS Stage I 1 Stenting of Sano
HLHS Stage I 1 Arch augmentation and pulmonary
vein debridement at BDG
HLHS Stage I 1 Stenting of ASD and Sano
HLHS Stage I 1 BD of ASD and PA, stenting of Sano
HLHS Stage I 1 BD of innominate vein
HLHS Stage I 1 BD of RPA, Sano stent
HLHC Stage I 1 LPA stent
HLHS Stage I 2 BD of Sano
HLHS Stage I 2 Sano stent
HLHS Stage I 2 Sano and ASD stent
UCAVC Stage I 2 BD of PA and arch
UCAVC Stage I 2 Atrial septectomy at BDG
HLHS Stage I 3 BD arch and PA
HLHS Stage I 3 Upsize BTS, TV repair and PA-plasty,
pulmonary vein dilation
HLHS Stage I 3 BD of PA before BDG, BD of arch
after BDG, BD of MV
DILV, TAPVR Stage I 3 BD of pulmonary veins
Category 4 (n ¼ 17)
Hypoplastic arch, VSD Arch augment, PA band 1 BD of PA band, surgical removal
of PA band
TAPVR TAPVR repair 1 BD of pulmonary veins
HLHS Comprehensive stage II 1 LPA stent
HLHS Comprehensive stage II 1 BD of ascending aorta, aortoplasty
at Fontan
Tet/PA/MAPCAS Unifocalization 1 BD of PAs
UCAVC, CoA Arch augmentation 1 AVV repair
IAA IAA repair 1 BD of arch
DOLV/PA Rastelli 1 Late pacemaker for 2 block
Truncus Truncus repair 2 BD of PAs, PA-plasty,
Tet/PA/MAPCAS Unifocalization 2 BD and conduit stent 3 2, BD PA
Tet/PA/MAPCAS Unifocalization 2 Multiple PA rehabilitation, PVR
Heterotaxy, discontinuous PAs Unifocalization 2 BD of PA, central PA-plasty at BDG
Hypoplastic arch, VSD Arch augment, VSD closure 2 Sub-AS resection
TGA/VSD ASO, VSD 3 OHT
TGA/VSD ASO, VSD 3 BD of branch PAs
Tet/PA/MAPCAS Unifocalization 3 PA rehabilitation
Truncus Truncus repair 3 PA rehabilitation, PA-plasty
Category 3 (n ¼ 14)
Tet/PA Repair with RV-PA conduit 1 Conduit change
DORV, straddling TV and
hypoplastic RV
BTS 1 Catheter to BD, PA after BiV repair,
reoperation for residual VSD,
pacemaker
HLHC Aortic and mitral valve plasty 1 BD of MV
1 TV and mitral valve-plasty
(Continued)
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TABLE E2. Continued
RACHS-1 category Diagnosis Procedure TPS Reintervention detail
Aortic regurgitation and
root dilation, CT disorder
Valve sparing; aortic root
replacement and ASC aortic
replacement
TOF/CAVC Tet canal repair 2 BD of pulmonary valve and RPA
William’s Aortoplasty, MPA and LPA plasty 2 BD of PAs
TGA/IVS ASO 2 BD of supra-PS
Tet/PA, single collateral Tet PA repair with RV-PA conduit 2 BD of distal conduit, conduit
change, stent in second conduit
CAVC CAVC repair 2 Sub-AS resection
TOF/APV Repair with RV-PA conduit 2 RPA BD, conduit change
Tricuspid atresia BTS 3 BD of PAs, PA-plasty at BDG,
PA-platy after BDG
CAVC CAVC repair 3 Redo ASD and cleft closure
Previous IAA repair with Ross
Konno, now with LCA
and conduit stenosis
Intraoperative stenting of LCA,
conduit change
3 BD of PA, OHT
Tet/AVC Tet canal repair 3 ASD stent and BD
of pulmonary veins
Category 2 (n ¼ 3)
TOF TOF repair 2 BD of supra-PS
TOF TOF repair 2 BD of RVOT
Pulmonary atresia/IVS, after BTS BDG 2 BD to rehabilitation PA, stenting
of PA, BD of SVC anastomosis
to PA
RACHS-1, Risk Adjustment for Congenital Heart Surgery-1; TPS, Technical Performance Score; HLHS, hypoplastic left heart syndrome; BD, balloon dilation; CoA, coarctation
of aorta; LPA, left pulmonary artery; OHT, orthotopic heart transplantation; TV, tricuspid valve; BDG, bidirectional Glenn; ASD, atrial septal defect; PA, pulmonary artery; RPA,
right pulmonary artery; UCAVC, unbalanced complete atrioventricular canal; BTS, Blalock-Taussig shunt; MV, mitral valve; DILV, double inlet left ventricle; VSD, ventricular
septal defect; TAPVR, total anomalous pulmonary venous return; Tet, tetralogy; RV, right ventricle; ASO, arterial switch operation; TGA, transposition of great arteries; PS, pul-
monary stenosis; MAPCA, major aortopulmonary collateral; AVC, atrioventricular canal; IAA, interrupted aortic arch; DOLV, double outlet left ventricle; BiV, biventricular; CT,
connective tissue; TOF, tetralogy of Fallot; RVOT, right ventricular outflow tract; CAVC, complete atrioventricular canal;MPA,main pulmonary artery; LCA, left coronary artery;
SVC, superior vena cava; HLHC, hypoplastic left heart complex; AVV, atrioventricular valve; IVS, intact ventricular septum.
TABLE E3. Late mortality/transplantation and relationship to late
reinterventions
Late reintervention
Late mortality
TotalAlive Dead
No 98 6 104 (6%)
Yes 47 8 55 (15%)
Total 145 14 159
TABLE E4. Effect of stratified TPS, by age and then RACHS-1
category for late death/transplantation
Variable Patients (n) Deaths (n) P value
Neonate
TPS .02
Optimal/adequate 63 5 (7.9%)
Inadequate 15 5 (33.3%)
Non-neonate
TPS .05
Optimal/adequate 73 2 (2.7%)
Inadequate 8 2 (25.0%)
RACHS category 2-3
TPS .05
Optimal/adequate 76 3 (4.0%)
Inadequate 7 2 (28.6%)
RACHS category 4-6
TPS .02
Optimal/adequate 60 4 (6.7%)
Inadequate 16 5 (31.3%)
TPS, Technical Performance Score; RACHS-1, Risk Adjustment for Congenital Heart
Surgery-1.
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TABLEE5. Effect of TPS, stratified by age andRACHS-1 category for
late reintervention
Variable Patients (n) Late reintervention (n)
P
value
Neonate
TPS 1.0
Optimal/adequate 63 27 (42.9%)
Inadequate 15 7 (46.7%)
Non-neonate
TPS .03
Optimal/adequate 73 16 (21.9%)
Inadequate 8 5 (62.5%)
RACHS Category 2-3
TPS .03
Optimal/adequate 76 13 (17.1%)
Inadequate 7 4 (57.1%)
RACHS category 4-6
TPS 1.0
Optimal/adequate 60 30 (50.0%)
Inadequate 16 8 (50.0%)
TPS, Technical Performance Score; RACHS-1, Risk Adjustment for Congenital Heart
Surgery-1.
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